NCT01912287View on ClinicalTrials.gov

GATE: Generalized Anxiety - A Treatment Evaluation

NACompletedINTERVENTIONAL
Enrollment

226

Participants

Timeline

Start Date

December 31, 2013

Primary Completion Date

April 29, 2019

Study Completion Date

October 25, 2019

Conditions
Generalized Anxiety Disorder
Interventions
BEHAVIORAL

Cognitive Behavioral Therapy

CBT focused on Generalized Anxiety Disorder (12 sessions)

BEHAVIORAL

Stress Education

Active control group (12 sessions)

BEHAVIORAL

Yoga

12 sessions, mindfulness components

Trial Locations (2)

02114

Massachusetts General Hospital, Boston

02215

Boston University, Boston

All Listed Sponsors
collaborator

National Center for Complementary and Integrative Health (NCCIH)

NIH

lead

NYU Langone Health

OTHER

NCT01912287 - GATE: Generalized Anxiety - A Treatment Evaluation | Biotech Hunter | Biotech Hunter